tetano
Editor, Senior Moderator
Curr Probl Cardiol
. 2022 Apr 20;101216.
doi: 10.1016/j.cpcardiol.2022.101216. Online ahead of print.
Impact of the COVID-19 pandemic on hospital admissions and in-hospital lethality from cardiovascular diseases in Brazil: an ecological and time series study COVID-19 and cardiovascular diseases
Lucas Gomes Santos[SUP] 1 [/SUP], Regicley Vieira da Silva[SUP] 2 [/SUP], Thiago Cavalcanti Leal[SUP] 2 [/SUP], José Emerson Xavier[SUP] 3 [/SUP], Elaine Virgínia Martins de Souza Figueiredo[SUP] 3 [/SUP], João Paulo Silva de Paiva[SUP] 2 [/SUP], Leonardo Feitosa da Silva[SUP] 2 [/SUP], Carlos Alberto de Oliveira Rocha[SUP] 2 [/SUP], Bruno Eduardo Bastos Rolim Nunes[SUP] 2 [/SUP], Gibson Barros de Almeida Santana[SUP] 2 [/SUP], Tânia Rita Moreno de Oliveira Fernandes[SUP] 4 [/SUP], Francisco de Assis Costa[SUP] 2 [/SUP], Márcio Bezerra-Santos[SUP] 5 [/SUP], Rodrigo Feliciano do Carmo[SUP] 6 [/SUP], Anderson da Costa Armstrong[SUP] 4 [/SUP], Carlos Dornels Freire de Souza[SUP] 2 [/SUP]
Affiliations
Abstract
Background: Since the onset of the coronavirus disease 2019 (COVID-19) pandemic in Brazil, several government policies have been taken. Herein, we aimed to assess the impact of the COVID-19 pandemic on hospital admissions and in-hospital lethality for cardiovascular diseases (CVD) in Brazil in 2020.
Methods: An ecological and time-series study on hospitalizations and deaths from CVD in Brazil was conducted from January 2018 to December 2020.
Results: The hospital admission rate for CVD reduced by 17.1%, with a significantly decreasing trend between January and May 2020 (Annual Percent Change: -8,7%; p-value <0.001). The in-hospital lethality rate increased from 8.2% in 2018 to 9.3% in 2020. During this period, Brazil totaled 21.8 million days of hospital stay.
Conclusion: Indicators of hospital admissions and lethality from CVD in Brazil were impacted by the emergence of the COVID-19 pandemic in different ways in the regions and depending on the nature of the indicator.
Keywords: COVID-19; Cardiovascular diseases; SARS-Cov2.
. 2022 Apr 20;101216.
doi: 10.1016/j.cpcardiol.2022.101216. Online ahead of print.
Impact of the COVID-19 pandemic on hospital admissions and in-hospital lethality from cardiovascular diseases in Brazil: an ecological and time series study COVID-19 and cardiovascular diseases
Lucas Gomes Santos[SUP] 1 [/SUP], Regicley Vieira da Silva[SUP] 2 [/SUP], Thiago Cavalcanti Leal[SUP] 2 [/SUP], José Emerson Xavier[SUP] 3 [/SUP], Elaine Virgínia Martins de Souza Figueiredo[SUP] 3 [/SUP], João Paulo Silva de Paiva[SUP] 2 [/SUP], Leonardo Feitosa da Silva[SUP] 2 [/SUP], Carlos Alberto de Oliveira Rocha[SUP] 2 [/SUP], Bruno Eduardo Bastos Rolim Nunes[SUP] 2 [/SUP], Gibson Barros de Almeida Santana[SUP] 2 [/SUP], Tânia Rita Moreno de Oliveira Fernandes[SUP] 4 [/SUP], Francisco de Assis Costa[SUP] 2 [/SUP], Márcio Bezerra-Santos[SUP] 5 [/SUP], Rodrigo Feliciano do Carmo[SUP] 6 [/SUP], Anderson da Costa Armstrong[SUP] 4 [/SUP], Carlos Dornels Freire de Souza[SUP] 2 [/SUP]
Affiliations
- PMID: 35460687
- PMCID: PMC9021219
- DOI: 10.1016/j.cpcardiol.2022.101216
Abstract
Background: Since the onset of the coronavirus disease 2019 (COVID-19) pandemic in Brazil, several government policies have been taken. Herein, we aimed to assess the impact of the COVID-19 pandemic on hospital admissions and in-hospital lethality for cardiovascular diseases (CVD) in Brazil in 2020.
Methods: An ecological and time-series study on hospitalizations and deaths from CVD in Brazil was conducted from January 2018 to December 2020.
Results: The hospital admission rate for CVD reduced by 17.1%, with a significantly decreasing trend between January and May 2020 (Annual Percent Change: -8,7%; p-value <0.001). The in-hospital lethality rate increased from 8.2% in 2018 to 9.3% in 2020. During this period, Brazil totaled 21.8 million days of hospital stay.
Conclusion: Indicators of hospital admissions and lethality from CVD in Brazil were impacted by the emergence of the COVID-19 pandemic in different ways in the regions and depending on the nature of the indicator.
Keywords: COVID-19; Cardiovascular diseases; SARS-Cov2.